16750023

Source:http://linkedlifedata.com/resource/pubmed/id/16750023

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021853, umls-concept:C0024305, umls-concept:C0205210, umls-concept:C0205225, umls-concept:C0936012
pubmed:issue	2
pubmed:dateCreated	2006-6-5
pubmed:abstractText	To investigate the clinical and pathological features, optimal treatment and prognostic factors in primary intestinal non-Hodgkin's lymphoma.
pubmed:language	chi
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7910681
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0253-3766
pubmed:author	pubmed-author:BaiChun-meiCM, pubmed-author:ChenShu-changSC, pubmed-author:LiuXiao-liXL, pubmed-author:ShenTiT, pubmed-author:XüYingY, pubmed-author:YangTiT, pubmed-author:ZhangWeiW, pubmed-author:ZhuYan-linYL
pubmed:issnType	Print
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	142-4
pubmed:meshHeading	pubmed-meshheading:16750023-Adult, pubmed-meshheading:16750023-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16750023-Cyclophosphamide, pubmed-meshheading:16750023-Doxorubicin, pubmed-meshheading:16750023-Female, pubmed-meshheading:16750023-Follow-Up Studies, pubmed-meshheading:16750023-Humans, pubmed-meshheading:16750023-Intestinal Neoplasms, pubmed-meshheading:16750023-Lymphoma, B-Cell, pubmed-meshheading:16750023-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:16750023-Lymphoma, Non-Hodgkin, pubmed-meshheading:16750023-Male, pubmed-meshheading:16750023-Middle Aged, pubmed-meshheading:16750023-Neoplasm Staging, pubmed-meshheading:16750023-Prednisone, pubmed-meshheading:16750023-Proportional Hazards Models, pubmed-meshheading:16750023-Remission Induction, pubmed-meshheading:16750023-Retrospective Studies, pubmed-meshheading:16750023-Survival Rate, pubmed-meshheading:16750023-Vincristine
pubmed:year	2006
pubmed:articleTitle	[Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
pubmed:affiliation	Department of Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China. baichunmei1964@yahoo.com.cn
pubmed:publicationType	Journal Article, English Abstract